(R,R)-Formoterol

(R,R)-Formoterol Struktur
67346-49-0
CAS-Nr.
67346-49-0
Englisch Name:
(R,R)-Formoterol
Synonyma:
Arformoterol;(R,R)-Formoterol;Arformoterol 13D3;Formoterol Impurity 10;(R,R)-Formoterol Impurity;(R,R)-Formoterol (Arformoterol);(-)-FORMOTEROL; ARFORMOTEROL; FORMOTEROL;Formoterol Impurity 10((R,R)-Formoterol)(Arformoterol);4-[(1R)-2-[[(1R)-2-(4-Methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl]-2-(formylamino)phenol;N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(αR)-α-methyl-4-methoxyphenethyl]amino]ethyl]phenyl]formamide
CBNumber:
CB81237087
Summenformel:
C19H24N2O4
Molgewicht:
344.4
MOL-Datei:
67346-49-0.mol

(R,R)-Formoterol Eigenschaften

Schmelzpunkt:
73-75 °C
Siedepunkt:
603.2±55.0 °C(Predicted)
Dichte
1.233±0.06 g/cm3(Predicted)
Löslichkeit
25℃: DMSO
Aggregatzustand
Powder
pka
8.95±0.50(Predicted)

Sicherheit

(R,R)-Formoterol Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Arformoterol, a selective long-acting b2-agonist, was launched as an inhalation solution for treatment of bronchoconstriction associated with COPD. It is the active (R,R)-enantiomer of the previously marketed b2-agonist formoterol, which is registered as a racemic mixture. Similar to other b2-agonists, the mechanism of action of formoterol and arformoterol involves activation of adenyl cyclase, leading to increased production of cyclic adenosine monophosphate (cAMP) via ATP. Increased levels of intracellular cAMP result in relaxation of the bronchial smooth muscle, and also prevent mast cells from releasing inflammatory mediators. Arformoterol has high binding affinity for the human b2 receptor (Kd 2.9 nM) and approximately 39-fold selectivity over the b1 receptor (Kd 113 nM). It is W1,000 times more potent b2 ligand than the corresponding (S,S)-enantiomer (Kd 3100 nM), and twice as potent as racemic formoterol (Kd 5.2 nM). Additionally, arformoterol acts as a full or nearly full agonist of the b2 receptor, whereas the (S,S)-enantiomer acts as an inverse agonist. Therefore, the (R,R)-enantiomer may account exclusively for the activation of b2 receptors by the racemic mixture.

Verwenden

(R,R)-Formoterol (Arformoterol) (CAS# 67346-49-0) is aused in the methods for treating chronic obstructive pulmonary disease by administration of a bronchodilator using a nebulizer.

Definition

ChEBI: An N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide in which both of the stereocentres have R configuration. The active enantiomer of formoterol, it is administered by inhalation generally as the tartrate salt) as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).

(R,R)-Formoterol Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(R,R)-Formoterol Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 63)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 11013 58
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
Jewim Pharmaceutical (Shandong) Co., Ltd.
+86-15552509998 +86-15621883869
liutf@jewim.com.cn China 251 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501
product@acmec-e.com China 33350 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
T&W GROUP 021-61551611 13296011611
contact@trustwe.com China 9900 58
Shanghai T&W Pharmaceutical Co., Ltd. +86 21 61551611
China 9901 58

  • N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
  • 4-[(1R)-2-[[(1R)-2-(4-Methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl]-2-(formylamino)phenol
  • N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(αR)-α-methyl-4-methoxyphenethyl]amino]ethyl]phenyl]formamide
  • N-[2-Hydroxy-5-[(R)-1-hydroxy-2-[[(R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide
  • Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-
  • Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [R-(R*,R*)]-
  • Arformoterol
  • (R,R)-Formoterol
  • Arformoterol 13D3
  • (-)-FORMOTEROL; ARFORMOTEROL; FORMOTEROL
  • (R,R)-Formoterol (Arformoterol)
  • Formoterol Impurity 10
  • Formoterol Impurity 10((R,R)-Formoterol)(Arformoterol)
  • ArformoterolQ: What is Arformoterol Q: What is the CAS Number of Arformoterol Q: What is the storage condition of Arformoterol
  • N-[2-hydroxy-5-[(1RS) - 1-hydroxy-2-[[(1RS) - 2 - (4-methoxyphenyl) - 1-methylethyl] amino] ethyl] phenyl] formamide
  • (R,R)-Formoterol Impurity
  • 67346-49-0
Copyright 2019 © ChemicalBook. All rights reserved